ABVE 📈 Above Food Ingredients - Overview
Exchange: NASDAQ • Country: Canada • Currency: USD • Type: Common Stock •
ABVE: Grain, Regenerative Ingredients, Bespoke Products, Food Formulations, Consumer Goods
Above Food Ingredients Inc., a regenerative ingredient company, produces vertically integrated supply chain products in Canada, the United States, Mexico, China, France, Turkey, and internationally. It operates through two segments: Disruptive Agriculture and Rudimentary Ingredients, and Consumer Packaged Goods. The Disruptive Agriculture and Rudimentary Ingredients segment engages in the provisioning of discrete genetics, origination, purchasing, grading, processing, and sale of regeneratively grown grain; and origination, purchase, and sale of bespoke ingredients products. The Consumer Packaged Goods segment formulates, manufactures, sells, distributes, and markets proprietary consumer product formulations in owned brands; and focuses on manufacturing and distribution for private-labeled retail owned brands. Above Food Ingredients Inc. is based in Regina, Canada. Web URL: https://abovefood.com
Additional Sources for ABVE Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ABVE Stock Overview
Market Cap in USD | 18m |
Sector | Consumer Defensive |
Industry | Packaged Foods |
GiC Sub-Industry | Agricultural Products & Services |
IPO / Inception | 2024-07-01 |
ABVE Stock Ratings
Growth 5y | -68.5% |
Fundamental | 23.0% |
Dividend | - |
Rel. Strength Industry | -717 |
Analysts | - |
Fair Price Momentum | 0.50 USD |
Fair Price DCF | 3.18 USD |
ABVE Dividends
No Dividends PaidABVE Growth Ratios
Growth Correlation 3m | -12.6% |
Growth Correlation 12m | -89.6% |
Growth Correlation 5y | -0.1% |
CAGR 5y | -61.46% |
CAGR/Mean DD 5y | -3.66 |
Sharpe Ratio 12m | -1.43 |
Alpha | -96.33 |
Beta | -0.15 |
Volatility | 181.03% |
Current Volume | 70.8k |
Average Volume 20d | 716.4k |
What is the price of ABVE stocks?
As of December 22, 2024, the stock is trading at USD 0.52 with a total of 70,808 shares traded.
Over the past week, the price has changed by +15.56%, over one month by -22.16%, over three months by -9.57% and over the past year by -95.07%.
As of December 22, 2024, the stock is trading at USD 0.52 with a total of 70,808 shares traded.
Over the past week, the price has changed by +15.56%, over one month by -22.16%, over three months by -9.57% and over the past year by -95.07%.
Is Above Food Ingredients a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Above Food Ingredients is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 23.00 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ABVE as of December 2024 is 0.50. This means that ABVE is currently overvalued and has a potential downside of -3.85%.
Neither. Based on ValueRay Fundamental Analyses, Above Food Ingredients is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 23.00 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ABVE as of December 2024 is 0.50. This means that ABVE is currently overvalued and has a potential downside of -3.85%.
Is ABVE a buy, sell or hold?
Above Food Ingredients has no consensus analysts rating.
Above Food Ingredients has no consensus analysts rating.
What are the forecast for ABVE stock price target?
According to ValueRays Forecast Model, ABVE Above Food Ingredients will be worth about 0.5 in December 2025. The stock is currently trading at 0.52. This means that the stock has a potential upside of +3.85%.
According to ValueRays Forecast Model, ABVE Above Food Ingredients will be worth about 0.5 in December 2025. The stock is currently trading at 0.52. This means that the stock has a potential upside of +3.85%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 0.5 | 3.8% |